RECQL and breast carcinoma: In sporadic ER- negative breast tumors, high RECQ1 expression is associated with poor survival in patients that received anthracycline based chemotherapy; and RECQ1-depletion in breast cancer cells increased doxorubicin chemosensitivity owing to DNA double strand breaks accumulation, S-phase cell cycle arrest and apoptosis [47].